Earnings Updates: HWDN, MEDP

Two quality businesses trading at attractive multiples and worthy of further research today

Medpace

Medpace’s first quarter revealed continued weakness in the contract research organization (CRO) industry. The post-COVID era, when capital was flooding the industry, has suffered from a bullwhip effect. Many biotech ideas that got easy funding in 2020 and 2021 have run out of money and capital providers are more cautious about funding new ideas.

…